Literature DB >> 8604178

Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership.

D A Goldmann1, R A Weinstein, R P Wenzel, O C Tablan, R J Duma, R P Gaynes, J Schlosser, W J Martone.   

Abstract

OBJECTIVE: To provide hospital leaders with strategic goals or actions likely to have a significant impact on antimicrobial resistance, outline outcome and process measures for evaluating progress toward each goal, describe potential barriers to success, and suggest countermeasures and novel improvement strategies. PARTICIPANTS: A multidisciplinary group of experts was drawn from the following areas: hospital epidemiology and infection control, infectious diseases (including graduate training programs), clinical practice (including nursing, surgery, internal medicine, and pediatrics), pharmacy, administration, quality improvement, appropriateness evaluation, behavior modification, practice guideline development, medical informatics, and outcomes research. Representatives from appropriate federal agencies, the Joint Commission on Accreditation of Healthcare Organizations, and the pharmaceutical industry also participated. EVIDENCE: Published literature, guidelines, expert opinion, and practical experience regarding efforts to improve antibiotic utilization and prevent and control the emergence and dissemination of antimicrobial-resistant microorganisms in hospitals. CONSENSUS PROCESS: Participants were divided into two quality improvement teams: one focusing on improving antimicrobial usage and the other on preventing and controlling transmission of resistant microorganisms. The teams modeled the process a hospital might use to develop and implement a strategic plan to combat antimicrobial resistance.
CONCLUSIONS: Ten strategic goals and related process and outcome measures were agreed on. The five strategic goals to optimize antimicrobial use were as follows: optimizing antimicrobial prophylaxis for operative procedures; optimizing choice and duration of empiric therapy; improving antimicrobial prescribing by educational and administrative means; monitoring and providing feedback regarding antibiotic resistance; and defining and implementing health care delivery system guidelines for important types of antimicrobial use. The five strategic goals to detect, report, and prevent transmission of antimicrobial resistant organisms were as follows: to develop a system to recognize and report trends in antimicrobial resistance within the institution; develop a system to rapidly detect and report resistant microorganisms in individual patients and ensure a rapid response by caregivers; increase adherence to basic infection control policies and procedures; incorporate the detection, prevention, and control of antimicrobial resistance into institutional strategic goals and provide the required resources; and develop a plan for identifying, transferring, discharging, and readmitting patients colonized with specific antimicrobial-resistant pathogens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8604178

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  108 in total

1.  The contributions of biomedical informatics to the fight against bioterrorism.

Authors:  Isaac S Kohane
Journal:  J Am Med Inform Assoc       Date:  2002 Mar-Apr       Impact factor: 4.497

Review 2.  Preventing postoperative infections: current treatment recommendations.

Authors:  I C Gyssens
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

3.  The identification of barriers preventing the successful implementation of a surgical prophylaxis protocol.

Authors:  Kathryn M Burnett; Michael G Scott; Patricia M Kearney; W George Humphreys; Robert M McMillen
Journal:  Pharm World Sci       Date:  2002-10

4.  Development of a clinical data warehouse for hospital infection control.

Authors:  Mary F Wisniewski; Piotr Kieszkowski; Brandon M Zagorski; William E Trick; Michael Sommers; Robert A Weinstein
Journal:  J Am Med Inform Assoc       Date:  2003-06-04       Impact factor: 4.497

5.  Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci.

Authors:  M Bertin; A Muller; X Bertrand; C Cornette; M Thouverez; D Talon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

Review 6.  Rapid detection of antimicrobial-resistant organism carriage: an unmet clinical need.

Authors:  Daniel J Diekema; Kirsty J Dodgson; Bryndis Sigurdardottir; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  Structured representation of the pharmacodynamics section of the summary of product characteristics for antibiotics: application for automated extraction and visualization of their antimicrobial activity spectra.

Authors:  Catherine Duclos; Gian Luigi Cartolano; Michael Ghez; Alain Venot
Journal:  J Am Med Inform Assoc       Date:  2004-04-02       Impact factor: 4.497

8.  Comparison of hospital-wide and unit-specific cumulative antibiograms in hospital- and community-acquired infection.

Authors:  F Lamoth; A Wenger; G Prod'hom; Y Vallet; C Plüss-Suard; J Bille; G Zanetti
Journal:  Infection       Date:  2010-06-16       Impact factor: 3.553

9.  Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria.

Authors:  E Raineri; L Crema; S Dal Zoppo; A Acquarolo; A Pan; G Carnevale; F Albertario; A Candiani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

10.  Prospective assessment of fluoroquinolone use in a teaching hospital.

Authors:  M Méan; P Pavese; J P Vittoz; L Foroni; C Decouchon; J P Stahl; P François
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.